242 related articles for article (PubMed ID: 7480899)
41. Trends in adverse events after IV administration of contrast media.
Cochran ST; Bomyea K; Sayre JW
AJR Am J Roentgenol; 2001 Jun; 176(6):1385-8. PubMed ID: 11373197
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the effects of noniodinized and iodinized ionic contrast media and gadoteric acid in acute necrotizing pancreatitis: experimental study in rabbits.
Apodaca-Torrez FR; Goldenberg A; Lobo EJ; Farah JF; Triviño T; Montero EF; Schraibman V; Benvenuto RB; Artigiani Neto R
Pancreas; 2007 Nov; 35(4):e41-4. PubMed ID: 18090230
[TBL] [Abstract][Full Text] [Related]
43. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.
Katayama H; Yamaguchi K; Kozuka T; Takashima T; Seez P; Matsuura K
Radiology; 1990 Jun; 175(3):621-8. PubMed ID: 2343107
[TBL] [Abstract][Full Text] [Related]
44. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial.
Barrett BJ; Parfrey PS; McDonald JR; Hefferton DM; Reddy ER; McManamon PJ
Radiology; 1992 Apr; 183(1):105-10. PubMed ID: 1549654
[TBL] [Abstract][Full Text] [Related]
45. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
Wiklund LM; Brolin I; Sjöholm K
Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
[TBL] [Abstract][Full Text] [Related]
46. Contrast media reactions and extravasation: relationship to intravenous injection rates.
Jacobs JE; Birnbaum BA; Langlotz CP
Radiology; 1998 Nov; 209(2):411-6. PubMed ID: 9807567
[TBL] [Abstract][Full Text] [Related]
47. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP.
Draganov PV; Forsmark CE
Gastrointest Endosc; 2008 Dec; 68(6):1098-101. PubMed ID: 19028218
[TBL] [Abstract][Full Text] [Related]
48. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
[TBL] [Abstract][Full Text] [Related]
49. Cytokine profiles after nonionic dimeric contrast medium injection.
Böhm I; Speck U; Schild H
Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
[TBL] [Abstract][Full Text] [Related]
50. Urine viscosity after injections of iotrolan or iomeprol.
Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Kubo K; Nakashima T
Acta Radiol; 1997 Nov; 38(6):1079-82. PubMed ID: 9394674
[TBL] [Abstract][Full Text] [Related]
51. Muscular and central nervous system side effects of intracarotid contrast media in rabbits.
Whisson CC; Evill CA; Wilson CA; Sage MR
Invest Radiol; 1990 Sep; 25 Suppl 1():S90-1. PubMed ID: 2283271
[No Abstract] [Full Text] [Related]
52. Adverse reactions to contrast media in CT: effects of temperature and ionic property.
Vergara M; Seguel S
Radiology; 1996 May; 199(2):363-6. PubMed ID: 8668779
[TBL] [Abstract][Full Text] [Related]
53. [Delayed adverse reactions following the intravascular administration of a nonionic x-ray contrast medium].
Beyer-Enke SA; Zeitler E; Schneider R
Radiologe; 1992 Apr; 32(4):165-9. PubMed ID: 1598412
[TBL] [Abstract][Full Text] [Related]
54. Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs.
Kurabayashi T; Ida M; Fukayama H; Ohbayashi N; Yoshino N; Sasaki T
Dentomaxillofac Radiol; 1998 Jul; 27(4):199-202. PubMed ID: 9780895
[TBL] [Abstract][Full Text] [Related]
55. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
[TBL] [Abstract][Full Text] [Related]
56. Safety of iodinated intravenous contrast medium administration in sickle cell disease.
Campbell KL; Hud LM; Adams S; Andrel J; Ballas SK; Feldman AM; Axelrod D
Am J Med; 2012 Jan; 125(1):100.e11-6. PubMed ID: 22195536
[TBL] [Abstract][Full Text] [Related]
57. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
Schmerwitz W
Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
[TBL] [Abstract][Full Text] [Related]
58. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. I. Histamine release.
Akagi M; Tasaka K
Methods Find Exp Clin Pharmacol; 1991; 13(6):377-84. PubMed ID: 1715500
[TBL] [Abstract][Full Text] [Related]
59. Haemodynamic side effects of meglumine ioglicate, meglumine sodium ioxaglate and iohexol in aortofemoral angiography: comparison of a high-osmolar and two low-osmolar radiological contrast media.
Wiebe V; Straub H
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():78-84. PubMed ID: 6139084
[No Abstract] [Full Text] [Related]
60. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
